UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                       Pursuant to Section 13 or 15(d) of
                       The Securities Exchange Act of 1934



       Date of Report (date of earliest event reported): January 22, 2004


                           Commission File No. 0-11178
                                               --------


                           UTAH MEDICAL PRODUCTS, INC.
                           ---------------------------
             (Exact name of Registrant as specified in its charter)


                      UTAH                                87-0342734
        -------------------------------                  -----------
        (State or other jurisdiction of                (I.R.S. Employer
        incorporation or organization)                Identification No.)


                               7043 South 300 West
                               Midvale, Utah 84047
                              -------------------
                     Address of principal executive offices


Registrant's telephone number:      (801) 566-1200
                                    --------------





--------------------------------------------------------------------------------
             ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
--------------------------------------------------------------------------------


Attached hereto as Exhibit 99.1 and incorporated by reference herein is
financial information for Utah Medical Products, Inc. for the quarter and year
ended December 31, 2003 and forward-looking statements relating to 2004 and
beyond as presented in a press release dated January 22, 2004. The information
in this report shall be deemed incorporated by reference into any registration
statement hertofore or hereafter filed under the Securities Act of 1933, as
amended, except to the extent that such information is superseded by information
as of a subsequent date that is included in or incorporated by reference into
such registration statement. The information in this report shall not be treated
as filed for purposes of the Securities Exchange Act of 1934, as amended.


--------------------------------------------------------------------------------
                                   SIGNATURES
--------------------------------------------------------------------------------



Pursuant to the requirements of the Securities Exchanges Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                        UTAH MEDICAL PRODUCTS, INC.
                                        ---------------------------
                                        REGISTRANT



Date: 1/22/2004                         By: /s/ Kevin L. Cornwell

                                            Kevin L. Cornwell
                                            CEO


--------------------------------------------------------------------------------

                                  EXHIBIT INDEX


Index
Number          Description
------          -----------


99.1            Financial  information  for Utah  Medical  Products,Inc.for the
                year and quarter ended December 31, 2003 and forward-looking
                statements relating to 2004 and beyond as presented in a press
                release dated January 22, 2004.